(-1.57%) 5 035.69 points
(-1.49%) 37 816 points
(-2.04%) 15 658 points
(-0.96%) $81.14
(-2.21%) $1.947
(-0.25%) $2 297.20
(0.17%) $26.70
(-0.50%) $943.50
(0.12%) $0.938
(0.28%) $11.13
(0.15%) $0.802
(0.00%) $93.45
0.15% ¥ 3 335.00
Live Chart Being Loaded With Signals
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan...
Stats | |
---|---|
Dagens volum | 8 800.00 |
Gjennomsnittsvolum | 76 644.00 |
Markedsverdi | 31.76B |
EPS | ¥0 ( 2024-02-08 ) |
Neste inntjeningsdato | ( ¥0 ) 2024-05-09 |
Last Dividend | ¥40.00 ( 2023-06-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 8.42 |
ATR14 | ¥3.17 (0.09%) |
Mizuho Medy Co.,Ltd. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Mizuho Medy Co.,Ltd. Økonomi
Annual | 2023 |
Omsetning: | ¥10.99B |
Bruttogevinst: | ¥8.03B (73.03 %) |
EPS: | ¥396.27 |
FY | 2023 |
Omsetning: | ¥10.99B |
Bruttogevinst: | ¥8.03B (73.03 %) |
EPS: | ¥396.27 |
FY | 2022 |
Omsetning: | ¥17.58B |
Bruttogevinst: | ¥14.10B (80.20 %) |
EPS: | ¥822.94 |
Financial Reports:
No articles found.
Mizuho Medy Co.,Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥190.00 (N/A) |
¥0 (N/A) |
¥40.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥9.25 | 2015-12-28 |
Last Dividend | ¥40.00 | 2023-06-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 12 | -- |
Total Paid Out | ¥555.75 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.82 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.40 | |
Div. Directional Score | 7.34 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8285.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7673.T | Ex Dividend Junior | 2024-05-30 | Annually | 0 | 0.00% | |
6855.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6203.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
4929.T | Ex Dividend Junior | 2024-03-18 | Annually | 0 | 0.00% | |
4099.T | Ex Dividend Junior | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
3315.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
2384.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
9312.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
8043.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.343 | 1.500 | 3.13 | 4.70 | [0 - 0.5] |
returnOnAssetsTTM | 0.199 | 1.200 | 3.36 | 4.03 | [0 - 0.3] |
returnOnEquityTTM | 0.262 | 1.500 | 8.20 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 7.15 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 6.38 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 3.82 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0511 | -1.500 | 9.15 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 41.05 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 41.05 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0618 | -1.500 | 9.75 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.735 | 1.000 | 1.089 | 1.089 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.469 | 1.000 | 2.62 | 2.62 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.404 | 1.000 | 8.87 | 8.87 | [0.2 - 2] |
assetTurnoverTTM | 0.580 | 0.800 | 9.47 | 7.57 | [0.5 - 2] |
Total Score | 10.28 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 8.38 | 1.000 | 9.25 | 0 | [1 - 100] |
returnOnEquityTTM | 0.262 | 2.50 | 8.84 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 41.05 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.41 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 41.05 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.134 | 1.500 | -2.44 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0356 | 1.000 | -1.611 | 0 | [0.1 - 0.5] |
Total Score | 4.40 |
Mizuho Medy Co.,Ltd.
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits. It also offers gene analysis instrument; SARS-CoV-2 detection kits; and mycoplasma pneumoniae nucleic acid kits. In addition, the company engages in import and export activities. It also operates in the United States, Belgium, Finland, Netherlands, Taiwan, Thailand, etc. The company was incorporated in 1977 and is headquartered in Tosu, Japan.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.